Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) is Gaining Momentum on...

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) is Gaining Momentum on Earnings Catalyst


The Fresenius Medical Care AG & Co. KGaA (FMS) shares are trading at higher $43.64 and the avg recommendation for the stock is Moderate Buy. The current analyst price target stands at $42.13.

To add more color to this target, the company’s high over the last year is $44.30 and the low is $29.17. Over the last 52 weeks, FMS is down -1.49% while the S&P 500 is up 1.07%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, FMS reported a profit of $1.56 billion. Fresenius Medical Care AG & Co. KGaA also saw revenues increase to $4.95 billion. In addition, FMS has free cash flow of $333.27 million as of 03-2020 The company’s EBITDA came in at $1.05 billion which compares well with its peers.

Find out when FMS reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. FMS has a short ratio of 1.15 and outstanding shares of 586.69M.

Company Outlook

FMS has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.16 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 3.69. Fresenius Medical Care AG & Co. KGaA FMS also noted assets of $37.59 billion at the end of the last quarter. Investors should also keep an eye on sector updates as FMS has historically followed its peers on positive news.

All told, Fresenius Medical Care AG & Co. KGaA FMS has strung together solid data and demonstrated underlying fundamentals. At its current valuation, FMS represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Fresenius Medical Care AG & Co. KGaA FMS is now commanding a market cap of 25.60B and a float of 401.28M. FMS is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of FMS stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in FMS, either long or short, and we have not been compensated for this article.